Feedback (LON:FDBK) Trading Up 14.5% Following Insider Buying Activity
by Renee Jackson · The Cerbat GemFeedback plc (LON:FDBK – Get Free Report) was up 14.5% on Wednesday after an insider bought additional shares in the company. The company traded as high as GBX 9.45 and last traded at GBX 9.45. Approximately 232,118 shares changed hands during mid-day trading, an increase of 144% from the average daily volume of 95,272 shares. The stock had previously closed at GBX 8.25.
Specifically, insider Emma Oswick (Stuart) bought 60,459 shares of the firm’s stock in a transaction on Tuesday, December 23rd. The shares were bought at an average price of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley purchased 60,904 shares of the company’s stock in a transaction on Tuesday, December 23rd. The stock was purchased at an average price of GBX 8 per share, with a total value of £4,872.32.
Feedback Trading Up 14.5%
The firm has a market cap of £4.14 million, a PE ratio of -0.37 and a beta of 0.77. The firm’s 50 day simple moving average is GBX 8.50 and its 200 day simple moving average is GBX 11.53.
Feedback Company Profile
Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.
Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.
By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.
Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.